Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Short-term management of insomnia Age: Adult |
Dose: Immediate release tablet – 5-10 mg Frequency: immediately before bedtime Duration: Maximum duration of treatment: 4 weeks including tapering Note: Maximum dose: 10 mg/day. |
|
Indication: Short-term management of insomnia Age: Elderly |
Dose: Immediate release tablet – 5 mg Frequency: immediately before bedtime Duration: Maximum duration of treatment: 4 weeks including tapering |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: Not recommended |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Form – Not specified Note: Renal impairment: No dosage adjustment needed. |
Administration
- Take on empty stomach
- Take immediately before bedtime
Side Effect
- Dizziness (5-12%)
- Headache (7-19%)
- Drowsiness (6-15%)
- Allergy (4%)
- Hallucinations (4%)
- Myalgia (4%)
- Sinusitis (4%)
- Memory disorder (3%)
- Visual disturbance (3%)
- Pharyngitis (3%)
- Lightheadedness (2%)
- Palpitation (2%)
- Rash (2%)
- Constipation (2%)
- Depression (2%)
- Drowsiness (2%)
- Asthenia (1%)
- Diarrhea (1%)
- Dry mouth (1%)
- Flu-like symptoms (1%)
- Hepatitis
- anaphylactic reactions
- angioedema
- sleep-driving (driving while not fully awake after drug intake, w/ no recollection of the event)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Flumazenil
|
Reverses the sedative/hypnotic effect of zolpidem
|
|
CNS depressants (e.g. sedatives, Antihistamines (Diphenhydramine, Loratadine, Levocetirizine, Cetirizine, Fexofenadine, Hydroxyzine, Bilastin), alcohol)
|
Increased depressant effects
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Severe Hepatic Impairment
|
Risk of excessive sedation and toxicity
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 20-25° C.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.